{{about|a [[substituted amphetamine]]}}
{{Drugbox
| Watchedfields = changed
| verifiedrevid = 443531339
| IUPAC_name = 1-(2,3-dihydro-1,4-benzodioxin-6-yl)-''N''-methylpropan-2-amine
| image = EDMA.png

<!--Clinical data-->
| tradename =  
| licence_EU = <!-- EMEA requires brand name -->
| licence_US = <!-- FDA may use generic name -->
| DailyMedID = <!-- preference to licence_US -->
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = Schedule III
| legal_UK = Class B
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = 
| routes_of_administration = [[Mouth|Oral]]

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number =  
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 24257269
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 23553090

<!--Chemical data-->
| C = 12 | H = 17 | N = 1 | O = 2
| molecular_weight = 207.269 g/mol
| smiles = CC(Cc1ccc2c(c1)OCCO2)NC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C12H17NO2/c1-9(13-2)7-10-3-4-11-12(8-10)15-6-5-14-11/h3-4,8-9,13H,5-7H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = UJKWLAZYSLJTKA-UHFFFAOYSA-N
| synonyms =  
| density =  
| melting_notes =  
| boiling_point =  
| solubility =  
| specific_rotation =  
| sec_combustion =  
}}

'''3,4-Ethylenedioxy-''N''-methylamphetamine''' ('''EDMA''') is an [[entactogen]] [[drug]] of the [[substituted amphetamine|amphetamine class]].<ref name="isbn0-9630096-0-5">{{cite book | author = Ann Shulgin | author2 = Alexander Shulgin | title = Pihkal: A Chemical Love Story | publisher = Transform Press | location = | year = 1991 | pages = | isbn = 0-9630096-0-5 | oclc = | doi = | url = http://isomerdesign.com/PiHKAL/read.php?domain=pk&id=110}}</ref><ref name="pmid1829838">{{cite journal | vauthors = McKenna DJ, Guan XM, Shulgin AT | title = 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine | journal = Pharmacology, Biochemistry, and Behavior | volume = 38 | issue = 3 | pages = 505–12 |date=March 1991 | pmid = 1829838 | doi = 10.1016/0091-3057(91)90005-M| url = http://linkinghub.elsevier.com/retrieve/pii/0091-3057(91)90005-M}}</ref> It is an [[structural analog|analogue]] of [[3,4-methylenedioxy-N-methylamphetamine|MDMA]] where the [[methylenedioxy]] [[functional group|ring]] has been replaced by an [[ethylenedioxy]] ring.<ref name="isbn0-9630096-0-5"/><ref name="pmid1829838"/> EDMA was first synthesized by [[Alexander Shulgin]].<ref name="isbn0-9630096-0-5"/> In his book ''[[PiHKAL]]'', the dosage is listed as 150–250&nbsp;mg, and the duration listed as 3–5 hours.<ref name="isbn0-9630096-0-5"/> According to Shulgin, EDMA produces a bare threshold consisting of [[paresthesia]], [[nystagmus]], and [[hypnogogic]] [[mental imagery|imagery]], with few to no other effects.<ref name="isbn0-9630096-0-5"/> Scientific research has demonstrated that EDMA acts as a non-[[neurotoxic]] [[serotonin releasing agent]] with moderately diminished [[potency (pharmacology)|potency]] relative to MDMA, and with negligible effects on [[dopamine]] release.<ref name="pmid1829838"/> 

== References ==
{{Reflist}}

== External links ==
* [http://www.erowid.org/library/books_online/pihkal/pihkal110.shtml EDMA entry in ''PiHKAL'']
* [http://pihkal.info/read.php?domain=pk&id=110 MDMC (EDMA) entry in PiHKAL • info]

{{Entactogens}}
{{Monoamine releasing agents}}
{{Phenethylamines}}
{{PiHKAL}}

[[Category:Designer drugs]]
[[Category:Benzodioxins]]
[[Category:Serotonin releasing agents]]
[[Category:Methamphetamines]]
[[Category:Substituted amphetamines]]